CORT vs LH · P/E 199, rev $421.1M vs P/E 23, rev $7.27B
Corcept Therapeutics Incorporated (CORT) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the CORT and LH stock pages for the full models.
Not investment advice.